LivaNova price target raised to $62 from $56 at Baird

Baird raised the firm’s price target on LivaNova to $62 from $56 and keeps a Neutral rating on the shares. The firm said they see upside potential to the company’s FY24 revenue/EPS outlook, however to justify a more attractive long-term risk/reward, they look for more confidence in management’s direction.